Skip to content

Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia

Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy in Women With Endometrial Neoplasia; Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03698604
Enrollment
52
Registered
2018-10-09
Start date
2018-01-01
Completion date
2018-08-01
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysterectomy, Laparoscopy

Brief summary

The aim of this study is to compare operative time between total laparoscopy hysterectomy with bilateral salpingoophrectomy (TLH+BSO) versus total abdominal hysterectomy and bilateral salpingooophorectomy (TAH+BSO) in women with uterine neoplasia.

Detailed description

Research Questions: Is total laparoscopic hysterectomy associated with similar operative operative time as total abdominal hysterectomy and bilateral salpingoophrectomy in women with uterine neoplasia? Research Hypothesis: In women with uterine neoplasia TLH with BSO may be similar to TAH with BSO as regard operative time.

Interventions

PROCEDUREHysterectomy

Total Laparoscopic Hysterectomy Total Abdominal hysterectomy

Sponsors

Ain Shams Maternity Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

The presence of perimenopausal bleeding * Early stage endometrial carcinoma. * Endometrial hyperplasia with/without atypia.

Exclusion criteria

* Obese patients i.e., BMI\< 29 k.g/m2. * Patients unfit for laparoscopy as patients with cardio-pulmonary compromise. * Presence of adnexal mass. * End stage endometrial carcinoma stage 3 & 4.

Design outcomes

Primary

MeasureTime frameDescription
Operative timeFrom skin incision till closure of the vault up to 4 hours.Operative time measured in minutes using stopwatch excluding time of concomitant surgical procedures.

Secondary

MeasureTime frameDescription
Blood transfusionFrom admission to the hospital until the home discharge up to 1 week.The need to blood transfusion to the patient.
Postoperative pain8 hours after the end of operation.Assessment of pain intensity using Visual Analog Scale (VAS) which is one-dimensional measure of pain intensity. It is a continuous scale comprised of a horizontal line, 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme. The scale is anchored by no pain (score of 0) and pain as bad as it could be or worst imaginable pain (score of 100).
Blood lossFrom skin incision start until skin suturing is finished up to 4 hours.Intra operative blood loss will be estimated via: 1. Amount of blood in the suction bottle. 2. Estimation will be based on number of soaked gauzes and towels (soaked gauze = 20 ml blood; soaked towel = 150 ml; semi soaked towel = 75 ml).
Incidence of operative complicationsDuring operation.The need for laparotomy, and bowel or bladder or ureteric injury.
Incidence of postoperative complicationsUp to 1 week postoperative.Morbidities e.g.: * Vaginal vault hematoma or pelvic hematoma or abscess. * Surgical site infection. * Urinary tract infection. * Need for post-operative blood transfusion. * Postoperative bowel or urinary tract complications.
Hospital stayFrom admission to the hospital until the home discharge up to 1 week.Hospital stay duration in days.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026